{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:33:38Z","timestamp":1779258818567,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1038\/leu.2016.92","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T06:56:40Z","timestamp":1461913000000},"page":"1942-1945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gab2 is essential for Bcr-Abl-mediated leukemic transformation and hydronephrosis in a chronic myeloid leukemia mouse model"],"prefix":"10.1038","volume":"30","author":[{"given":"S","family":"Halbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F M","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Zeiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Koschmieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Aumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Brummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"BFleu201692_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","volume":"75","author":"AM Pendergast","year":"1993","unstructured":"Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175\u2013185.","journal-title":"Cell"},{"key":"BFleu201692_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1478-811X-7-22","volume":"7","author":"FU Wohrle","year":"2009","unstructured":"Wohrle FU, Daly RJ, Brummer T . Function, regulation and pathological roles of the Gab\/DOS docking proteins. Cell Commun Signal 2009; 7: 22.","journal-title":"Cell Commun Signal"},{"key":"BFleu201692_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1535-6108(02)00074-0","volume":"1","author":"M Sattler","year":"2002","unstructured":"Sattler M, Mohi MG, Pride YB, Quinnan LR, Malouf NA, Podar K et al. Critical role for Gab2 in transformation by BCR\/ABL. Cancer Cell 2002; 1: 479\u2013492.","journal-title":"Cancer Cell"},{"key":"BFleu201692_CR4","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1182\/blood-2015-06-653006","volume":"127","author":"S Gu","year":"2016","unstructured":"Gu S, Chan WW, Mohi G, Rosenbaum J, Sayad A, Lu Z et al. Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1. Blood 2016; 127: 1803\u20131813.","journal-title":"Blood"},{"key":"BFleu201692_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/leu.2012.222","volume":"27","author":"FU Wohrle","year":"2013","unstructured":"Wohrle FU, Halbach S, Aumann K, Schwemmers S, Braun S, Auberger P et al. Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors. Leukemia 2013; 27: 118\u2013129.","journal-title":"Leukemia"},{"key":"BFleu201692_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1478-811X-11-30","volume":"11","author":"S Halbach","year":"2013","unstructured":"Halbach S, Rigbolt KT, Wohrle FU, Diedrich B, Gretzmeier C, Brummer T et al. Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells. Cell Commun Signal 2013; 11: 30.","journal-title":"Cell Commun Signal"},{"key":"BFleu201692_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12964-016-0129-y","volume":"14","author":"S Halbach","year":"2016","unstructured":"Halbach S, Hu Z, Gretzmeier C, Ellermann J, Wohrle FU, Dengjel J et al. Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Cell Commun Signal 2016; 14: 6.","journal-title":"Cell Commun Signal"},{"key":"BFleu201692_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.humpath.2010.09.012","volume":"42","author":"K Aumann","year":"2011","unstructured":"Aumann K, Lassmann S, Schopflin A, May AM, Wohrle FU, Zeiser R et al. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia. Hum Pathol 2011; 42: 719\u2013726.","journal-title":"Hum Pathol"},{"key":"BFleu201692_CR9","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1182\/blood-2003-12-4369","volume":"105","author":"S Koschmieder","year":"2005","unstructured":"Koschmieder S, Gottgens B, Zhang P, Iwasaki-Arai J, Akashi K, Kutok JL et al. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. Blood 2005; 105: 324\u2013334.","journal-title":"Blood"},{"key":"BFleu201692_CR10","first-page":"65","volume":"1","author":"S Koschmieder","year":"2011","unstructured":"Koschmieder S, Schemionek M . Mouse models as tools to understand and study BCR-ABL1 diseases. Am J Blood Res 2011; 1: 65\u201375.","journal-title":"Am J Blood Res"},{"key":"BFleu201692_CR11","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1182\/blood-2009-04-215376","volume":"115","author":"M Schemionek","year":"2010","unstructured":"Schemionek M, Elling C, Steidl U, Baumer N, Hamilton A, Spieker T et al. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells. Blood 2010; 115: 3185\u20133195.","journal-title":"Blood"},{"key":"BFleu201692_CR12","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1182\/blood.V99.5.1866","volume":"99","author":"K Nishida","year":"2002","unstructured":"Nishida K, Wang L, Morii E, Park SJ, Narimatsu M, Itoh S et al. Requirement of Gab2 for mast cell development and KitL\/c-Kit signaling. Blood 2002; 99: 1866\u20131869.","journal-title":"Blood"},{"key":"BFleu201692_CR13","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1182\/blood.V97.3.720","volume":"97","author":"TL Holyoake","year":"2001","unstructured":"Holyoake TL, Jiang X, Jorgensen HG, Graham S, Alcorn MJ, Laird C et al. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3. Blood 2001; 97: 720\u2013728.","journal-title":"Blood"},{"key":"BFleu201692_CR14","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1038\/bcj.2014.89","volume":"4","author":"M Askmyr","year":"2014","unstructured":"Askmyr M, Agerstam H, Lilljebjorn H, Hansen N, Karlsson C, von Palffy S et al. Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells. Blood Cancer J 2014; 4: e269.","journal-title":"Blood Cancer J"},{"key":"BFleu201692_CR15","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1158\/0008-5472.CAN-06-1346","volume":"66","author":"K Kometani","year":"2006","unstructured":"Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M et al. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model. Cancer Res 2006; 66: 9967\u20139976.","journal-title":"Cancer Res"},{"key":"BFleu201692_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/cmdc.201500484","volume":"11","author":"D Bier","year":"2015","unstructured":"Bier D, Bartel M, Sies K, Halbach S, Higuchi Y, Haranosono Y et al. Small-molecule stabilization of the 14-3-3\/Gab2 protein-protein interaction (PPI) interface. ChemMedChem 2015; 11: 911\u2013918.","journal-title":"ChemMedChem"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201692","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201692.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T17:21:54Z","timestamp":1648747314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["BFleu201692"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.92","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"assertion":[{"value":"29 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}